Year |
Citation |
Score |
Low-probability matches (unlikely to be authored by this person) |
2024 |
Cha DS, Kleine N, Teopiz KM, Di Vincenzo JD, Ho R, Galibert SL, Samra A, Zilm SPM, Cha RH, d'Andrea G, Gill H, Ceban F, Meshkat S, Wong S, Le GH, ... ... Rosenblat JD, et al. The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysis. Expert Opinion On Pharmacotherapy. PMID 38164653 DOI: 10.1080/14656566.2023.2298340 |
0.01 |
|
2024 |
McIntyre RS, Kwan ATH, Rosenblat JD, Teopiz KM, Mansur RB. Psychotropic Drug-Related Weight Gain and Its Treatment. The American Journal of Psychiatry. 181: 26-38. PMID 38161305 DOI: 10.1176/appi.ajp.20230922 |
0.01 |
|
2023 |
d'Andrea G, Pettorruso M, Di Lorenzo G, Rhee TG, Chiappini S, Carullo R, Barlati S, Zanardi R, Rosso G, Di Nicola M, Andriola I, Marcatili M, Clerici M, Dell'Osso BM, Sensi SL, ... ... Rosenblat JD, et al. The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data. Journal of Affective Disorders. PMID 38145840 DOI: 10.1016/j.jad.2023.12.038 |
0.01 |
|
2023 |
Kwan ATH, Al-Kassimi K, Portnoff JS, Singh G, Hanafimosalman M, Tesla M, Gharibi N, Ni T, Guo Z, Sonfack DJN, Martyniuk J, Arfaie S, Mashayekhi MS, Mofatteh M, Jeremian R, ... ... Rosenblat JD, et al. Association of SARS-CoV-2 infection with neurological impairments in pediatric population: A systematic review. Journal of Psychiatric Research. 170: 90-110. PMID 38134724 DOI: 10.1016/j.jpsychires.2023.12.005 |
0.01 |
|
2023 |
Le GH, Kwan ATH, Wong S, Guo Z, Teopiz KM, Badulescu S, Meshkat S, d'Andrea G, Ho R, Rhee TG, Cao B, Phan L, Rosenblat JD, Mansur RB, Subramaniapillai M, et al. Impact of Elevated Body Mass Index (BMI) on Hedonic Tone in Persons with Post-COVID-19 Condition: A Secondary Analysis. Advances in Therapy. PMID 38114867 DOI: 10.1007/s12325-023-02760-2 |
0.01 |
|
2023 |
McIntyre RS, Mansur RB, Rosenblat JD, Kwan ATH. The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS). Expert Opinion On Drug Safety. 1-9. PMID 38087976 DOI: 10.1080/14740338.2023.2295397 |
0.01 |
|
2023 |
Rosenblat JD, McIntyre RS. Augmentation in depression: Esketamine, a new standard? Med (New York, N.Y.). 4: 852-854. PMID 38070477 DOI: 10.1016/j.medj.2023.11.002 |
0.01 |
|
2023 |
McIntyre RS, Phan L, Kwan ATH, Mansur RB, Rosenblat JD, Guo Z, Le GH, Lui LMW, Teopiz KM, Ceban F, Lee Y, Bailey J, Ramachandra R, Di Vincenzo J, Badulescu S, et al. Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial. Brain : a Journal of Neurology. PMID 37936330 DOI: 10.1093/brain/awad377 |
0.01 |
|
2023 |
Haikazian S, Chen-Li DCJ, Johnson DE, Fancy F, Levinta A, Husain MI, Mansur RB, McIntyre RS, Rosenblat JD. Psilocybin-assisted therapy for depression: A systematic review and meta-analysis. Psychiatry Research. 329: 115531. PMID 37844352 DOI: 10.1016/j.psychres.2023.115531 |
0.01 |
|
2023 |
Ceban F, Kulzhabayeva D, Rodrigues NB, Di Vincenzo JD, Gill H, Subramaniapillai M, Lui LMW, Cao B, Mansur RB, Ho RC, Burke MJ, Rhee TG, Rosenblat JD, McIntyre RS. Corrigendum to "COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis" [Brain Behav. Immun. 111 (2023) 211-229]. Brain, Behavior, and Immunity. PMID 37806865 DOI: 10.1016/j.bbi.2023.09.020 |
0.01 |
|
2023 |
Akbar D, Rhee TG, Ceban F, Ho R, Teopiz KM, Cao B, Subramaniapillai M, Kwan ATH, Rosenblat JD, McIntyre RS. Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials. Cns Drugs. 37: 867-881. PMID 37792265 DOI: 10.1007/s40263-023-01032-5 |
0.01 |
|
2023 |
Fancy F, Haikazian S, Johnson DE, Chen-Li DCJ, Levinta A, Husain MI, Mansur RB, Rosenblat JD. Ketamine for bipolar depression: an updated systematic review. Therapeutic Advances in Psychopharmacology. 13: 20451253231202723. PMID 37771417 DOI: 10.1177/20451253231202723 |
0.01 |
|
2023 |
McIntyre RS, Alsuwaidan M, Baune BT, Berk M, Demyttenaere K, Goldberg JF, Gorwood P, Ho R, Kasper S, Kennedy SH, Ly-Uson J, Mansur RB, McAllister-Williams RH, Murrough JW, Nemeroff CB, ... ... Rosenblat JD, et al. Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 22: 394-412. PMID 37713549 DOI: 10.1002/wps.21120 |
0.01 |
|
2023 |
Wong S, Yu AY, Fabiano N, Finkelstein O, Pasricha A, Jones BDM, Rosenblat JD, Blumberger DM, Mulsant BH, Husain MI. Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders. Journal of Psychoactive Drugs. 1-17. PMID 37615379 DOI: 10.1080/02791072.2023.2251133 |
0.01 |
|
2023 |
Pettorruso M, Guidotti R, d'Andrea G, De Risio L, D'Andrea A, Chiappini S, Carullo R, Barlati S, Zanardi R, Rosso G, De Filippis S, Di Nicola M, Andriola I, Marcatili M, Nicolò G, ... ... Rosenblat JD, et al. Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING). Psychiatry Research. 327: 115378. PMID 37574600 DOI: 10.1016/j.psychres.2023.115378 |
0.01 |
|
2023 |
Meshkat S, Teopiz KM, Di Vincenzo JD, Bailey JBB, Rosenblat JD, Ho RC, Rhee TG, Ceban F, Kwan ATH, Cao B, McIntyre RS. Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder. Journal of Affective Disorders. PMID 37557991 DOI: 10.1016/j.jad.2023.08.027 |
0.01 |
|
2023 |
Cha DS, Carmona NE, Rodrigues NB, Mansur RB, Lee Y, Subramaniapillai M, Phan L, Cha RH, Pan Z, Lee JH, Lee J, Almatham F, Alageel A, Rosenblat JD, Shekotikhina M, et al. Corrigendum to "Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in major depressive disorder" [J. Affect. Disord.. 238, 2018, pages 228-232]. Journal of Affective Disorders. 340: 71. PMID 37556871 DOI: 10.1016/j.jad.2023.07.062 |
0.01 |
|
2023 |
Husain MI, Blumberger DM, Castle DJ, Ledwos N, Fellows E, Jones BDM, Ortiz A, Kloiber S, Wang W, Rosenblat JD, Mulsant BH. Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial. Bjpsych Open. 9: e134. PMID 37489299 DOI: 10.1192/bjo.2023.535 |
0.01 |
|
2023 |
Chisamore N, Danayan K, Rodrigues NB, Di Vincenzo JD, Meshkat S, Doyle Z, Mansur R, Phan L, Fancy F, Chau E, Tabassum A, Kratiuk K, Arekapudi A, McIntyre RS, Rosenblat JD. Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth. Journal of Psychopharmacology (Oxford, England). 2698811231171531. PMID 37194253 DOI: 10.1177/02698811231171531 |
0.01 |
|
2023 |
Di Vincenzo JD, O'Brien L, Jacobs I, Jawad MY, Ceban F, Meshkat S, Gill H, Tabassum A, Phan L, Badulescu S, Rosenblat JD, McIntyre RS, Mansur RB. Indirect Calorimetry to Measure Metabolic Rate and Energy Expenditure in Psychiatric Populations: A Systematic Review. Nutrients. 15. PMID 37049526 DOI: 10.3390/nu15071686 |
0.01 |
|
2023 |
Ceban F, Kulzhabayeva D, Rodrigues NB, Di Vincenzo JD, Gill H, Subramaniapillai M, Lui LMW, Cao B, Mansur RB, Ho RC, Burke MJ, Rhee TG, Rosenblat JD, McIntyre RS. COVID-19 Vaccination for the Prevention and Treatment of Long COVID: A Systematic Review and Meta-analysis. Brain, Behavior, and Immunity. PMID 36990297 DOI: 10.1016/j.bbi.2023.03.022 |
0.01 |
|
2023 |
Lee DY, Han SY, Lee K, Lee Y, Phan L, Mansur RB, Rosenblat JD, McIntyre RS. Association of a low protein diet with depressive symptoms and poor health-related quality of life in CKD. Journal of Psychiatric Research. 161: 282-288. PMID 36947959 DOI: 10.1016/j.jpsychires.2023.02.032 |
0.01 |
|
2023 |
Johnson DE, McIntyre RS, Mansur RB, Rosenblat JD. An update on potential pharmacotherapies for cognitive impairment in bipolar disorder. Expert Opinion On Pharmacotherapy. 1-14. PMID 36946229 DOI: 10.1080/14656566.2023.2194488 |
0.01 |
|
2023 |
Rosenblat JD, Leon-Carlyle M, Ali S, Husain MI, McIntyre RS. Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects. The American Journal of Psychiatry. appiajp20220835. PMID 36945824 DOI: 10.1176/appi.ajp.20220835 |
0.01 |
|
2023 |
Kwan ATH, Al-Kassimi K, Portnoff JS, Tesla M, Hanafimosalman M, Gharibi N, Ni T, Sonfack DJN, Martyniuk J, Arfaie S, Mashayekhi MS, Mofatteh M, Jeremian R, Moscote-Salazar LR, Lee Á, ... ... Rosenblat JD, et al. Association of SARS-CoV-2 Infection with Neurological Symptoms and Neuroimaging Manifestations in the Pediatric Population: A Systematic Review. Research Square. PMID 36945594 DOI: 10.21203/rs.3.rs-2653722/v1 |
0.01 |
|
2023 |
Danayan K, Chisamore N, Rodrigues NB, Vincenzo JDD, Meshkat S, Doyle Z, Mansur R, Phan L, Fancy F, Chau E, Tabassum A, Kratiuk K, Arekapudi A, Teopiz KM, McIntyre RS, ... Rosenblat JD, et al. Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorder. Psychiatry Research. 323: 115133. PMID 36889160 DOI: 10.1016/j.psychres.2023.115133 |
0.01 |
|
2023 |
Chudzicka-Czupała A, Hapon N, Chiang SK, Żywiołek-Szeja M, Karamushka L, Lee CT, Grabowski D, Paliga M, Rosenblat JD, Ho R, McIntyre RS, Chen YL. Depression, anxiety and post-traumatic stress during the 2022 Russo-Ukrainian war, a comparison between populations in Poland, Ukraine, and Taiwan. Scientific Reports. 13: 3602. PMID 36869035 DOI: 10.1038/s41598-023-28729-3 |
0.01 |
|
2023 |
Husain MI, Ledwos N, Fellows E, Baer J, Rosenblat JD, Blumberger DM, Mulsant BH, Castle DJ. Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action? Frontiers in Psychiatry. 13: 1076459. PMID 36844032 DOI: 10.3389/fpsyt.2022.1076459 |
0.01 |
|
2023 |
Gill H, McIntyre RS, Hawco C, Rodrigues NB, Gill B, DiVincenzo JD, Lieberman JM, Marks CA, Cha DS, Lipsitz O, Nazal H, Jasrai A, Rosenblat JD, Mansur RB. Evaluating the neural substrates of effort-expenditure for reward in adults with major depressive disorder and obesity. Psychiatry Research. Neuroimaging. 329: 111592. PMID 36708594 DOI: 10.1016/j.pscychresns.2023.111592 |
0.01 |
|
2023 |
Ceban F, Subramaniapillai M, Mansur RB, Rosenblat JD, McIntyre RS. Can COVID-19 have a Clinically Significant Effect on Drug Metabolism? Expert Opinion On Drug Safety. PMID 36691834 DOI: 10.1080/14740338.2023.2172158 |
0.01 |
|
2023 |
Rosenblat JD, deVries FE, Doyle Z, McIntyre RS, Rodin G, Zimmermann C, Mak E, Hannon B, Schulz-Quach C, Kindy AA, Patel Z, Li M. A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study). Cancers. 15. PMID 36672348 DOI: 10.3390/cancers15020400 |
0.01 |
|
2023 |
Meshkat S, Haikazian S, D Di Vincenzo J, Fancy F, Johnson D, Chen-Li D, McIntyre RS, Mansur R, Rosenblat JD. Oral Ketamine for Depression: An Updated Systematic Review. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-36. PMID 36651238 DOI: 10.1080/15622975.2023.2169349 |
0.01 |
|
2022 |
Meshkat S, Rosenblat JD, Ho RC, Rhee TG, Cao B, Ceban F, Danayan K, Chisamore N, Vincenzo JDD, McIntyre RS. Ketamine use in pediatric depression: A systematic review. Psychiatry Research. 317: 114911. PMID 37732856 DOI: 10.1016/j.psychres.2022.114911 |
0.01 |
|
2022 |
Gillissie ES, Le GH, Rhee TG, Cao B, Rosenblat JD, Mansur RB, Ho RC, McIntyre RS. Evaluating Anhedonia as a risk factor in suicidality: A meta-analysis. Journal of Psychiatric Research. 158: 209-215. PMID 36603315 DOI: 10.1016/j.jpsychires.2022.12.024 |
0.01 |
|
2022 |
Vazquez G, Gutierrez G, Rosenblat J, Schaffer A, Swainson J, Karthikeyan G, Ravindran N, Lam RW, Do A, Giacobbe P, Hawken E, Milev R. Association of intranasal esketamine, a novel 'standard of care' treatment and outcomes in the management of patients with treatment-resistant depression: protocol of a prospective cohort observational study of naturalistic clinical practice. Bmj Open. 12: e060967. PMID 36581972 DOI: 10.1136/bmjopen-2022-060967 |
0.01 |
|
2022 |
Meshkat S, Ho RC, Cao B, Teopiz KM, Rosenblat JD, Rhee TG, Di Vincenzo JD, Ceban F, Jawad MY, McIntyre RS. Biomarkers of ketamine's antidepressant effect: An umbrella review. Journal of Affective Disorders. 323: 598-606. PMID 36521662 DOI: 10.1016/j.jad.2022.12.021 |
0.01 |
|
2022 |
Fancy F, Rodrigues NB, Di Vincenzo JD, Chau EH, Sethi R, Husain MI, Gill H, Tabassum A, Mckenzie A, Phan L, McIntyre RS, Rosenblat JD. Real World Effectiveness of Repeated Ketamine Infusions for Treatment Resistant Bipolar Depression. Bipolar Disorders. PMID 36516343 DOI: 10.1111/bdi.13284 |
0.01 |
|
2022 |
Rashidian H, Subramaniapillai M, Park C, Lipsitz O, Zuckerman H, Cao B, Lee Y, Gill H, Rodrigues RN, Di Vincenzo JD, Iacobucci M, Jaberi S, Rosenblat JD, McIntyre RS, Mansur RB. Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder. Journal of Psychopharmacology (Oxford, England). 2698811221132473. PMID 36377525 DOI: 10.1177/02698811221132473 |
0.01 |
|
2022 |
Jawad MY, Di Vincenzo JD, Badulescu S, Teopiz KM, Tabassum A, Ceban F, Mckenzie A, Meshkat S, Rosenblat JD, Ho RC, McIntyre RS. The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression. Neuropharmacology. 223: 109299. PMID 36336068 DOI: 10.1016/j.neuropharm.2022.109299 |
0.01 |
|
2022 |
McIntyre RS, Lipsitz O, Rodrigues NB, Subramaniapillai M, Nasri F, Lee Y, Fehnert B, King J, Chrones L, Kratiuk K, Uddin S, Rosenblat JD, Mansur RB, McCue M. An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study. Jmir Mental Health. 9: e33871. PMID 36301615 DOI: 10.2196/33871 |
0.01 |
|
2022 |
Chen-Li D, Lui LMW, Rosenblat JD, Lipsitz O, Teopiz KM, Ho R, Vinberg M, Golts M, Jawad MY, Lee Y, Nasri F, Gill H, McIntyre RS. Ketamine as potential treatment for postpartum depression: A narrative review. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 34: 264-274. PMID 36282614 DOI: 10.12788/acp.0082 |
0.01 |
|
2022 |
Jawad MY, Meshkat S, Tabassum A, Mckenzie A, Di Vincenzo JD, Guo Z, Musavi NB, Phan L, Ceban F, Kwan AT, Ramachandra R, Le GH, Mansur RB, Rosenblat JD, Ho R, et al. The Bi-directional Association of Nonalcoholic Fatty Liver Disease with Depression, Bipolar Disorder and Schizophrenia. Cns Spectrums. 1-44. PMID 36268655 DOI: 10.1017/S1092852922001043 |
0.01 |
|
2022 |
Meshkat S, Alnefeesi Y, Jawad MY, D Di Vincenzo J, B Rodrigues N, Ceban F, Mw Lui L, McIntyre RS, Rosenblat JD. Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review & meta-analysis. Psychiatry Research. 317: 114857. PMID 36194941 DOI: 10.1016/j.psychres.2022.114857 |
0.01 |
|
2022 |
Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI. A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap. Journal of Clinical Psychopharmacology. 42: 581-588. PMID 36193898 DOI: 10.1097/JCP.0000000000001608 |
0.01 |
|
2022 |
Solmi M, Chen C, Daure C, Buot A, Ljuslin M, Verroust V, Mallet L, Khazaal Y, Rothen S, Thorens G, Zullino D, Gobbi G, Rosenblat J, Husain MI, De Gregorio D, et al. A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 64: 44-60. PMID 36191546 DOI: 10.1016/j.euroneuro.2022.09.004 |
0.01 |
|
2022 |
Lee DY, Yoo DK, Han SY, Lee K, Lee Y, Teopiz KM, Mansur RB, Rosenblat JD, McIntyre RS. Association between depressive symptoms and bone density in elderly patients with non-dialysis dependent chronic kidney disease. Journal of Affective Disorders. PMID 36113692 DOI: 10.1016/j.jad.2022.09.014 |
0.01 |
|
2022 |
Pouyan N, Halvaei Khankahdani Z, Younesi Sisi F, Lee Y, Rosenblat JD, Teopiz KM, Lui LMW, Subramaniapillai M, Lin K, Nasri F, Rodrigues N, Gill H, Lipsitz O, Cao B, Ho R, et al. A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review. Cns Drugs. PMID 36097251 DOI: 10.1007/s40263-022-00944-y |
0.01 |
|
2022 |
Levinta A, Meshkat S, McIntyre RS, Ho C, Lui LMW, Lee Y, Mansur RB, Teopiz KM, Rodrigues NB, Di Vincenzo JD, Ceban F, Rosenblat JD. The association between stage of treatment-resistant depression and clinical utility of ketamine/esketamine: A systematic review. Journal of Affective Disorders. 318: 139-149. PMID 36049604 DOI: 10.1016/j.jad.2022.08.050 |
0.01 |
|
2022 |
Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenwaym KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, et al. The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 7067437221111371. PMID 35975555 DOI: 10.1177/07067437221111371 |
0.01 |
|
2022 |
Joneborg I, Lee Y, Di Vincenzo JD, Ceban F, Meshkat S, Lui LMW, Fancy F, Rosenblat JD, McIntyre RS. Active mechanisms of ketamine-assisted psychotherapy: A systematic review. Journal of Affective Disorders. 315: 105-112. PMID 35905796 DOI: 10.1016/j.jad.2022.07.030 |
0.01 |
|
2022 |
Gill H, Rodrigues NB, Mansur RB, Marks CA, DiVincenzo JD, Ceban F, Rosenblat JD, Cao B, Ho R, McIntyre RS. The effect of adjunctive infliximab treatment on future cardiovascular disease risk in patients with bipolar disorder. Journal of Affective Disorders. PMID 35878838 DOI: 10.1016/j.jad.2022.07.020 |
0.01 |
|
2022 |
Jawad MY, Alnefeesi Y, Ceban F, Lui LMW, Jaberi S, Di Vincenzo JD, Amirbeik L, Chen-Li DCJ, Teopiz K, Phan L, Cao B, Ho R, Rosenblat JD, McIntyre RS. Lumateperone for the Treatment of Adults With Schizophrenia: a Systematic Review. Current Psychiatry Reports. PMID 35802228 DOI: 10.1007/s11920-022-01344-1 |
0.01 |
|
2022 |
Alnefeesi Y, Chen-Li D, Krane E, Jawad MY, Rodrigues NB, Ceban F, Di Vincenzo JD, Meshkat S, Ho RCM, Gill H, Teopiz KM, Cao B, Lee Y, McIntyre RS, Rosenblat JD. Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis. Journal of Psychiatric Research. 151: 693-709. PMID 35688035 DOI: 10.1016/j.jpsychires.2022.04.037 |
0.01 |
|
2022 |
Le TT, Cordero IP, Jawad MY, Swainson J, Di Vincenzo JD, Jaberi S, Phan L, Lui LMW, Ho R, Rosenblat JD, McIntyre RS. The abuse liability of ketamine: A scoping review of preclinical and clinical studies. Journal of Psychiatric Research. 151: 476-496. PMID 35623124 DOI: 10.1016/j.jpsychires.2022.04.035 |
0.01 |
|
2022 |
Gutierrez G, Rosenblat J, Hawken E, Swainson J, Vazquez G. Efficacy and Tolerability of Two Novel "Standard of Care" Treatments-Intranasal Esketamine Versus Intravenous Ketamine-for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational Study. Jmir Research Protocols. 11: e34711. PMID 35604752 DOI: 10.2196/34711 |
0.01 |
|
2022 |
Gill H, Puramat P, Patel P, Gill B, Marks CA, Rodrigues NB, Castle D, Cha DS, Mansur RB, Rosenblat JD, McIntyre RS. The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies. Psychiatry Research. 313: 114577. PMID 35580433 DOI: 10.1016/j.psychres.2022.114577 |
0.01 |
|
2022 |
Benitah K, Siegel AN, Lipsitz O, Rodrigues NB, Meshkat S, Lee Y, Mansur RB, Nasri F, Lui LMW, McIntyre RS, Rosenblat JD. Sex differences in ketamine's therapeutic effects for mood disorders: A systematic review. Psychiatry Research. 312: 114579. PMID 35504148 DOI: 10.1016/j.psychres.2022.114579 |
0.01 |
|
2022 |
Nogo D, Nazal H, Song Y, Teopiz KM, Ho R, McIntyre RS, Lui LMW, Rosenblat JD. A review of potential neuropathological changes associated with ketamine. Expert Opinion On Drug Safety. 1-19. PMID 35502632 DOI: 10.1080/14740338.2022.2071867 |
0.01 |
|
2022 |
Doyle MA, Ling S, Lui LMW, Fragnelli P, Teopiz KM, Ho R, Di Vincenzo JD, Rosenblat JD, Gillissie ES, Nogo D, Ceban F, Jawad MY, McIntyre RS. Hallucinogen persisting perceptual disorder: a scoping review covering frequency, risk factors, prevention, and treatment. Expert Opinion On Drug Safety. 1-11. PMID 35426769 DOI: 10.1080/14740338.2022.2063273 |
0.01 |
|
2022 |
Jawad MY, Di Vincenzo JD, Ceban F, Jaberi S, Lui LMW, Gillissie ES, Alnafeesi Y, Rosenblat JD, McIntyre RS. The efficacy and safety of adjunctive intranasal esketamine treatment in major depressive disorder: a systematic review and meta-analysis. Expert Opinion On Drug Safety. 1-12. PMID 35387538 DOI: 10.1080/14740338.2022.2058488 |
0.01 |
|
2022 |
Nogo D, Jasrai AK, Kim H, Nasri F, Ceban F, Lui LMW, Rosenblat JD, Vinberg M, Ho R, McIntyre RS. The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits. Psychopharmacology. PMID 35292831 DOI: 10.1007/s00213-022-06105-9 |
0.01 |
|
2022 |
Ceban F, Leber A, Jawad MY, Yu M, Lui LMW, Subramaniapillai M, Di Vincenzo JD, Gill H, Rodrigues NB, Cao B, Lee Y, Lin K, Mansur RB, Ho R, Burke MJ, ... Rosenblat JD, et al. Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research. Infectious Diseases (London, England). 1-11. PMID 35282780 DOI: 10.1080/23744235.2022.2043560 |
0.01 |
|
2022 |
Jawad MY, Alnefeesi Y, Lui LMW, Ceban F, Chen-Li DCJ, Teopiz K, Jaberi S, Gillissie ES, Di Vincenzo JD, Rosenblat JD, McIntyre RS. Corrigendum to "Olanzapine and samidorphan combination treatment: A systematic review". Journal of Affective Disorders. Volume 301, 15 March 2022, Pages 99-106. Journal of Affective Disorders. 304: 167. PMID 35181148 DOI: 10.1016/j.jad.2022.02.010 |
0.01 |
|
2022 |
Xiao K, Gillissie ES, Lui LMW, Ceban F, Teopiz KM, Gill H, Cao B, Ho R, Rosenblat JD, McIntyre RS. Immune Response to Vaccination in Adults with Mental Disorders: A Systematic Review. Journal of Affective Disorders. PMID 35167926 DOI: 10.1016/j.jad.2022.02.025 |
0.01 |
|
2022 |
Jawad MY, Alnefeesi Y, Lui LMW, Ceban F, Chen-Li DCJ, Teopiz K, Jaberi S, Gillissie ES, Vincenzo JDD, Rosenblat JD, McIntyre RS. Olanzapine and Samidorphan Combination Treatment: A Systematic Review. Journal of Affective Disorders. PMID 35007644 DOI: 10.1016/j.jad.2022.01.004 |
0.01 |
|
2021 |
Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, Rodrigues NB, Subramaniapillai M, Di Vincenzo JD, Cao B, Lin K, Mansur RB, Ho RC, Rosenblat JD, Miskowiak KW, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain, Behavior, and Immunity. 101: 93-135. PMID 34973396 DOI: 10.1016/j.bbi.2021.12.020 |
0.01 |
|
2021 |
Liu YK, Ling S, Lui LMW, Ceban F, Vinberg M, Kessing LV, Ho RC, Rhee TG, Gill H, Cao B, Mansur RB, Lee Y, Rosenblat J, Teopiz KM, McIntyre RS. Prevalence of Type 2 Diabetes Mellitus, Impaired Fasting Glucose, General Obesity, and Abdominal Obesity in Patients with Bipolar Disorder: A Systematic Review and Meta-analysis. Journal of Affective Disorders. PMID 34965395 DOI: 10.1016/j.jad.2021.12.110 |
0.01 |
|
2021 |
El-Halabi S, Cooper DH, Cha DS, Rosenblat JD, Gill B, Rodrigues NB, Lipsitz O, McIntyre RS, Gill H. The effects of antidepressant medications on antiretroviral treatment adherence in HIV-positive individuals with depression. Journal of Affective Disorders. 300: 219-225. PMID 34952118 DOI: 10.1016/j.jad.2021.12.083 |
0.01 |
|
2021 |
Di Vincenzo JD, Lipsitz O, Rodrigues NB, Jones BDM, Gill H, Lee Y, Lui LMW, Teopiz KM, Ho R, Lin K, Nasri F, McIntyre RS, Rosenblat JD. Frequency analysis of symptomatic worsening following ketamine infusions for treatment resistant depression in a real-world sample: Results from the canadian rapid treatment center of excellence. Psychiatry Research. 307: 114321. PMID 34890909 DOI: 10.1016/j.psychres.2021.114321 |
0.01 |
|
2021 |
Meshkat S, Rodrigues NB, Di Vincenzo JD, Ceban F, Jaberi S, McIntyre RS, Lui LMW, Rosenblat JD. Pharmacogenomics of ketamine: A systematic review. Journal of Psychiatric Research. 145: 27-34. PMID 34844049 DOI: 10.1016/j.jpsychires.2021.11.036 |
0.01 |
|
2021 |
Gillissie ES, Lui LMW, Ceban F, Miskowiak K, Gok S, Cao B, Teopiz KM, Ho R, Lee Y, Rosenblat JD, McIntyre RS. Deficits of Social Cognition in Bipolar Disorder: Systematic Review and Meta-Analysis. Bipolar Disorders. PMID 34825440 DOI: 10.1111/bdi.13163 |
0.01 |
|
2021 |
Le TT, Di Vincenzo JD, Teopiz KM, Lee Y, Cha DS, Lui LMW, Rodrigues NB, Ho RC, Cao B, Lin K, Nasri F, Gill H, Lipsitz O, Subramaniapillai M, Mansur RB, ... Rosenblat JD, et al. Ketamine for psychotic depression: An overview of the glutamatergic system and ketamine's mechanisms associated with antidepressant and psychotomimetic effects. Psychiatry Research. 306: 114231. PMID 34798487 DOI: 10.1016/j.psychres.2021.114231 |
0.01 |
|
2021 |
Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS. Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression. Cns Drugs. PMID 34791625 DOI: 10.1007/s40263-021-00877-y |
0.01 |
|
2021 |
Lee Y, Lui LMW, Brietzke E, Liao Y, Lu C, Ho R, Subramaniapillai M, Mansur RB, Rosenblat JD, McIntyre RS. Comparing mortality from covid-19 to mortality due to overdose: A micromort analysis. Journal of Affective Disorders. 296: 514-521. PMID 34656039 DOI: 10.1016/j.jad.2021.09.059 |
0.01 |
|
2021 |
Renaud-Charest O, Lui LMW, Eskander S, Ceban F, Ho R, Di Vincenzo JD, Rosenblat JD, Lee Y, Subramaniapillai M, McIntyre RS. Onset and frequency of depression in post-COVID-19 syndrome: A systematic review. Journal of Psychiatric Research. 144: 129-137. PMID 34619491 DOI: 10.1016/j.jpsychires.2021.09.054 |
0.01 |
|
2021 |
McIntyre RS, Lui LM, Rosenblat JD, Ho R, Gill H, Mansur RB, Teopiz K, Liao Y, Lu C, Subramaniapillai M, Nasri F, Lee Y. Suicide reduction in Canada during the COVID-19 pandemic: lessons informing national prevention strategies for suicide reduction. Journal of the Royal Society of Medicine. 1410768211043186. PMID 34551280 DOI: 10.1177/01410768211043186 |
0.01 |
|
2021 |
Alnefeesi Y, Tamura J, Lui LMW, Jawad MY, Ceban F, Ling S, Nasri F, Rosenblat JD, McIntyre RS. Trace amine-associated receptor 1 (TAAR1): Potential Application in Mood Disorders: A Systematic Review. Neuroscience and Biobehavioral Reviews. PMID 34537265 DOI: 10.1016/j.neubiorev.2021.09.020 |
0.01 |
|
2021 |
Di Vincenzo JD, Lipsitz O, Rodrigues NB, Lee Y, Gill H, Kratiuk K, Subramaniapillai M, Mansur R, McIntyre RS, Rosenblat JD. Ketamine monotherapy versus adjunctive ketamine in adults with treatment-resistant depression: Results from the Canadian Rapid Treatment Centre of Excellence. Journal of Psychiatric Research. 143: 209-214. PMID 34507101 DOI: 10.1016/j.jpsychires.2021.09.002 |
0.01 |
|
2021 |
Nogo D, Wilkialis L, Lui LMW, Nasri F, Rosenblat JD, McIntyre RS. Examining the association between inflammation and motivational anhedonia in neuropsychiatric disorders: A systematic review. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 33: 193-206. PMID 34398735 DOI: 10.12788/acp.0034 |
0.01 |
|
2021 |
Ceban F, Rosenblat JD, Kratiuk K, Lee Y, Rodrigues NB, Gill H, Subramaniapillai M, Nasri F, Lui LMW, Lipsitz O, Kumar A, Lee JG, Chau EH, Cao B, Lin K, et al. Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders. Cns Drugs. PMID 34363603 DOI: 10.1007/s40263-021-00846-5 |
0.01 |
|
2021 |
McIntyre RS, Lipsitz O, Lui LMW, Rodrigues NB, Gill H, Nasri F, Ling R, Teopiz KM, Ho RC, Subramaniapillai M, Kratiuk K, Mansur RB, Jones BDM, Lee Y, Rosenblat JD. The meaningful change threshold as measured by the 16-item quick inventory of depressive symptomatology in adults with treatment-resistant major depressive and bipolar disorder receiving intravenous ketamine. Journal of Affective Disorders. 294: 592-596. PMID 34332360 DOI: 10.1016/j.jad.2021.07.035 |
0.01 |
|
2021 |
Ceban F, Nogo D, Carvalho IP, Lee Y, Nasri F, Xiong J, Lui LMW, Subramaniapillai M, Gill H, Liu RN, Joseph P, Teopiz KM, Cao B, Mansur RB, Lin K, ... Rosenblat JD, et al. Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death: A Systematic Review and Meta-analysis. Jama Psychiatry. PMID 34319365 DOI: 10.1001/jamapsychiatry.2021.1818 |
0.01 |
|
2021 |
Gill H, Rosenblat JD, Mansur RB, McIntyre RS. Inflammation and disease modification in bipolar disorders: Priority avenues for future research. Bipolar Disorders. PMID 34296499 DOI: 10.1111/bdi.13104 |
0.01 |
|
2021 |
Rosenblat JD, Lipsitz O, Di Vincenzo JD, Rodrigues NB, Kratiuk K, Subramaniapillai M, Lee Y, Arekapudi AK, Abrishami A, Chau EH, Szpejda W, Wong L, Mansur RB, McIntyre RS. Real-world effectiveness of repeated ketamine infusions for treatment resistant depression during the COVID-19 pandemic. Psychiatry Research. 303: 114086. PMID 34246008 DOI: 10.1016/j.psychres.2021.114086 |
0.01 |
|
2021 |
Ng J, Rosenblat JD, Lui LMW, Teopiz KM, Lee Y, Lipsitz O, Mansur RB, Rodrigues NB, Nasri F, Gill H, Cha DS, Subramaniapillai M, Ho RC, Cao B, McIntyre RS. Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic review. Journal of Affective Disorders. 293: 285-294. PMID 34225208 DOI: 10.1016/j.jad.2021.06.032 |
0.01 |
|
2021 |
McIntyre RS, Lee Y, Rodrigues NB, Nasri F, Lao G, Zeng W, Ye B, Li R, Rosenblat JD, Mansur RB, Subramaniapillai M, Lui LMW, Teopiz KM, Liu T, Xiong J, et al. Repetitive transcranial magnetic stimulation for cognitive function in adults with bipolar disorder: A pilot study. Journal of Affective Disorders. 293: 73-77. PMID 34174474 DOI: 10.1016/j.jad.2021.05.075 |
0.01 |
|
2021 |
McIntyre RS, Lipsitz O, Lui LMW, Rodrigues NB, Lee Y, Ho RC, Subramaniapillai M, Gill H, Cha DS, Lin K, Teopiz KM, Nasri F, Mansur RB, Kratiuk K, Rosenblat JD. Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression? Journal of Affective Disorders. 292: 714-719. PMID 34161889 DOI: 10.1016/j.jad.2021.05.090 |
0.01 |
|
2021 |
Rodrigues NB, McIntyre RS, Lipsitz O, Cha DS, Cao B, Lee Y, Gill H, Lui LMW, Cubała W, Ho R, Shekotikhina M, Teopiz KM, Subramaniapillai M, Kratiuk K, Mansur RB, ... Rosenblat JD, et al. Do sleep changes mediate the anti-depressive and anti-suicidal response of intravenous ketamine in treatment-resistant depression? Journal of Sleep Research. e13400. PMID 34137095 DOI: 10.1111/jsr.13400 |
0.01 |
|
2021 |
Lee Y, Lui LMW, Chen-Li D, Liao Y, Mansur RB, Brietzke E, Rosenblat JD, Ho R, Rodrigues NB, Lipsitz O, Nasri F, Cao B, Subramaniapillai M, Gill H, Lu C, et al. Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countries. Journal of Affective Disorders. 290: 364-377. PMID 34052584 DOI: 10.1016/j.jad.2021.04.050 |
0.01 |
|
2021 |
Siegel AN, Meshkat S, Benitah K, Lipsitz O, Gill H, Lui LMW, Teopiz KM, McIntyre RS, Rosenblat JD. Registered clinical studies investigating psychedelic drugs for psychiatric disorders. Journal of Psychiatric Research. 139: 71-81. PMID 34048997 DOI: 10.1016/j.jpsychires.2021.05.019 |
0.01 |
|
2021 |
McIntyre RS, Rosenblat JD, Rodrigues NB, Lipsitz O, Chen-Li D, Lee JG, Nasri F, Subramaniapillai M, Kratiuk K, Wang A, Gill H, Mansur RB, Ho R, Lin K, Lee Y. The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE). Psychiatry Research. 302: 113993. PMID 34034067 DOI: 10.1016/j.psychres.2021.113993 |
0.01 |
|
2021 |
McIntyre RS, Rodrigues NB, Lipsitz O, Lee Y, Cha DS, Gill H, Lui LMW, Subramaniapillai M, Kratiuk K, Ho R, Mansur RB, Rosenblat JD. Validation of the McIntyre And Rosenblat Rapid Response Scale (MARRRS) in Adults with Treatment-Resistant Depression Receiving Intravenous Ketamine Treatment. Journal of Affective Disorders. 288: 210-216. PMID 33965843 DOI: 10.1016/j.jad.2021.03.053 |
0.01 |
|
2021 |
McMullen EP, Lee Y, Lipsitz O, Lui LMW, Vinberg M, Ho R, Rodrigues NB, Rosenblat JD, Cao B, Gill H, Teopiz KM, Cha DS, McIntyre RS. Strategies to Prolong Ketamine's Efficacy in Adults with Treatment-Resistant Depression. Advances in Therapy. PMID 33929660 DOI: 10.1007/s12325-021-01732-8 |
0.01 |
|
2021 |
Siegel A, Zuo Y, Moghaddamcharkari N, McIntyre RS, Rosenblat JD. Barriers, benefits and interventions for improving the delivery of telemental health services during the coronavirus disease 2019 pandemic: a systematic review. Current Opinion in Psychiatry. 34: 434-443. PMID 33928918 DOI: 10.1097/YCO.0000000000000714 |
0.01 |
|
2021 |
Rodrigues NB, McIntyre RS, Lipsitz O, Lee Y, Subramaniapillai M, Kratiuk K, Majeed A, Nasri F, Gill H, Mansur RB, Rosenblat JD. The effect of repeated doses of intravenous ketamine on measures of workplace attendance and productivity in adults with major depressive and bipolar disorder: Results from the canadian rapid treatment center of excellence. Psychiatry Research. 300: 113860. PMID 33836470 DOI: 10.1016/j.psychres.2021.113860 |
0.01 |
|
2021 |
Gill H, Gill B, Lipsitz O, Rodrigues NB, Cha DS, El-Halabi S, Mansur RB, Rosenblat JD, Cooper DH, Lee Y, Nasri F, McIntyre RS. The impact of overweight/obesity on monetary reward processing: A systematic review. Journal of Psychiatric Research. 137: 456-464. PMID 33798972 DOI: 10.1016/j.jpsychires.2021.03.029 |
0.01 |
|
2021 |
Siegel AN, Di Vincenzo JD, Brietzke E, Gill H, Rodrigues NB, Lui LMW, Teopiz KM, Ng J, Ho R, McIntyre RS, Rosenblat JD. Antisuicidal and antidepressant effects of ketamine and esketamine in patients with baseline suicidality: A systematic review. Journal of Psychiatric Research. 137: 426-436. PMID 33774537 DOI: 10.1016/j.jpsychires.2021.03.009 |
0.01 |
|
2021 |
McIntyre RS, Rosenblat JD, Nemeroff CB, Sanacora G, Murrough JW, Berk M, Brietzke E, Dodd S, Gorwood P, Ho R, Iosifescu DV, Lopez Jaramillo C, Kasper S, Kratiuk K, Lee JG, et al. Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. The American Journal of Psychiatry. appiajp202020081251. PMID 33726522 DOI: 10.1176/appi.ajp.2020.20081251 |
0.01 |
|
2021 |
Tamura JK, Carvalho IP, Leanna LMW, Feng JN, Rosenblat JD, Mansur R, Lee Y, Cha DS, Teopiz K, Ahmad Z, Nasri F, Kim J, McIntyre RS. Management of cognitive impairment in bipolar disorder: a systematic review of randomized controlled trials. Cns Spectrums. 1-22. PMID 33706820 DOI: 10.1017/S1092852921000092 |
0.01 |
|
2021 |
Di Vincenzo JD, Siegel A, Lipsitz O, Ho R, Teopiz KM, Ng J, Lui LMW, Lin K, Cao B, Rodrigues NB, Gill H, McIntyre RS, Rosenblat JD. The effectiveness, safety and tolerability of ketamine for depression in adolescents and older adults: A systematic review. Journal of Psychiatric Research. 137: 232-241. PMID 33706168 DOI: 10.1016/j.jpsychires.2021.02.058 |
0.01 |
|
2021 |
Kim J, Uddin ZA, Lee Y, Nasri F, Gill H, Subramanieapillai M, Lee R, Udovica A, Phan L, Lui L, Iacobucci M, Mansur RB, Rosenblat JD, McIntyre RS. A Systematic review of the validity of screening depression through Facebook, Twitter, Instagram, and Snapchat. Journal of Affective Disorders. PMID 33691948 DOI: 10.1016/j.jad.2020.08.091 |
0.01 |
|
2021 |
Majeed A, Xiong J, Teopiz KM, Ng J, Ho R, Rosenblat JD, Phan L, Cao B, McIntyre RS. Efficacy of dextromethorphan for the treatment of depression: A systematic review of preclinical and clinical trials. Expert Opinion On Emerging Drugs. PMID 33682569 DOI: 10.1080/14728214.2021.1898588 |
0.01 |
|
2021 |
Lee Y, Mansur RB, Brietzke E, Kapogiannis D, Delgado-Peraza F, Boutilier JJ, Chan TCY, Carmona NE, Rosenblat JD, Lee J, Maletic V, Vinberg M, Suppes T, Goldstein BI, Ravindran AV, et al. Peripheral inflammatory biomarkers define biotypes of bipolar depression. Molecular Psychiatry. PMID 33658605 DOI: 10.1038/s41380-021-01051-y |
0.01 |
|
2021 |
Wilkialis L, Rodrigues N, Majeed A, Lee Y, Lipsitz O, Gill H, Tamura J, Nasri F, Lui LMW, Siegel A, Mansur RB, Rosenblat JD, McIntyre RS. Loneliness-based impaired reward system pathway: Theoretical and clinical analysis and application. Psychiatry Research. 298: 113800. PMID 33618235 DOI: 10.1016/j.psychres.2021.113800 |
0.01 |
|
2021 |
Cao B, Xu L, Wang D, Lee Y, Rosenblat JD, Gao X, Zhan S, Sun F, McIntyre RS. Comparative Efficacy of Pharmacological Treatments on Measures of Self -Rated Functional Outcomes Using the Sheehan Disability Scale in Patients with Major Depressive Disorder: A Systematic Review and Network Meta-analysis. Cns Spectrums. 1-28. PMID 33583460 DOI: 10.1017/S1092852921000171 |
0.01 |
|
2021 |
McIntyre RS, Lee Y, Rong C, Rosenblat JD, Brietzke E, Pan Z, Park C, Subramaniapillai M, Ragguett RM, Mansur RB, Lui LMW, Nasri F, Gill H, Berriah S. Ecological momentary assessment of depressive symptoms using the mind.me application: Convergence with the Patient Health Questionnaire-9 (PHQ-9). Journal of Psychiatric Research. 135: 311-317. PMID 33540296 DOI: 10.1016/j.jpsychires.2021.01.012 |
0.01 |
|
2021 |
Ng J, Lui LMW, Rosenblat JD, Teopiz KM, Lipsitz O, Cha DS, Xiong J, Nasri F, Lee Y, Kratiuk K, Rodrigues NB, Gill H, Subramaniapillai M, Mansur RB, Ho R, et al. Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment. Psychopharmacology. PMID 33484298 DOI: 10.1007/s00213-021-05767-1 |
0.01 |
|
2021 |
Lipsitz O, Di Vincenzo JD, Rodrigues NB, Cha DS, Lee Y, Greenberg D, Teopiz KM, Ho RC, Cao B, Lin K, Subramaniapillai M, Flint AJ, Kratiuk K, McIntyre RS, Rosenblat JD. Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 33478865 DOI: 10.1016/j.jagp.2020.12.032 |
0.01 |
|
2021 |
Lui LMW, Lee Y, Lipsitz O, Rodrigues NB, Gill H, Ma J, Wilkialis L, Tamura JK, Siegel A, Chen-Li D, Rosenblat JD, Mansur RB, McPherson MA, McIntyre RS. The Influence of Prescriber and Patient Gender on the Prescription of Benzodiazepines: Results from the Florida Medicaid Dataset. Cns Spectrums. 1-14. PMID 33461640 DOI: 10.1017/S1092852921000055 |
0.01 |
|
2020 |
Alnefeesi Y, Siegel A, Lui LMW, Teopiz KM, Ho RCM, Lee Y, Nasri F, Gill H, Lin K, Cao B, Rosenblat JD, McIntyre RS. Impact of SARS-CoV-2 Infection on Cognitive Function: A Systematic Review. Frontiers in Psychiatry. 11: 621773. PMID 33643083 DOI: 10.3389/fpsyt.2020.621773 |
0.01 |
|
2020 |
Rashidian H, Subramaniapillai M, Park C, Lipsitz O, Zuckerman H, Teopiz K, Cao B, Lee Y, Gill H, Ho R, Lin K, Rodrigues NB, Iacobucci M, Rosenblat JD, McIntyre RS, et al. Insulin resistance is associated with deficits in hedonic, self-reported cognitive, and psychosocial functional response to antidepressant treatment in individuals with major depressive disorder. Journal of Affective Disorders. 282: 448-453. PMID 33422821 DOI: 10.1016/j.jad.2020.12.074 |
0.01 |
|
2020 |
Rodrigues NB, McIntyre RS, Lipsitz O, Lee Y, Cha DS, Shekotikhina M, Vinberg M, Gill H, Subramaniapillai M, Kratiuk K, Lin K, Ho R, Mansur RB, Rosenblat JD. A simplified 6-Item clinician administered dissociative symptom scale (CADSS-6) for monitoring dissociative effects of sub-anesthetic ketamine infusions. Journal of Affective Disorders. 282: 160-164. PMID 33418362 DOI: 10.1016/j.jad.2020.12.119 |
0.01 |
|
2020 |
Xiong J, Lipsitz O, Chen-Li D, Rosenblat JD, Rodrigues NB, Carvalho I, Lui LMW, Gill H, Narsi F, Mansur RB, Lee Y, McIntyre RS. The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. Journal of Psychiatric Research. 134: 57-68. PMID 33360864 DOI: 10.1016/j.jpsychires.2020.12.038 |
0.01 |
|
2020 |
Mansur RB, Delgado-Peraza F, Subramaniapillai M, Lee Y, Iacobucci M, Nasri F, Rodrigues N, Rosenblat JD, Brietzke E, Cosgrove VE, Kramer NE, Suppes T, Raison CL, Fagiolini A, Rasgon N, et al. Exploring brain insulin resistance in adults with bipolar depression using extracellular vesicles of neuronal origin. Journal of Psychiatric Research. 133: 82-92. PMID 33316649 DOI: 10.1016/j.jpsychires.2020.12.007 |
0.01 |
|
2020 |
Rodrigues NB, Siegel A, Lipsitz O, Cha DS, Gill H, Nasri F, Simonson K, Shekotikhina M, Lee Y, Subramaniapillai M, Kratiuk K, Lin K, Ho R, Mansur RB, McIntyre RS, ... Rosenblat JD, et al. Effectiveness of Intravenous ketamine in Mood Disorder Patients with a History of Neurostimulation. Cns Spectrums. 1-22. PMID 33298225 DOI: 10.1017/S1092852920002187 |
0.01 |
|
2020 |
Mansur RB, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, Iacobucci M, Rodrigues N, Nasri F, Rosenblat JD, Brietzke E, Cosgrove VE, Kramer NE, Suppes T, Newport J, et al. Effects of infliximab on brain neurochemistry of adults with bipolar depression. Journal of Affective Disorders. 281: 61-66. PMID 33296798 DOI: 10.1016/j.jad.2020.11.128 |
0.01 |
|
2020 |
McIntyre RS, Berk M, Brietzke E, Goldstein BI, López-Jaramillo C, Kessing LV, Malhi GS, Nierenberg AA, Rosenblat JD, Majeed A, Vieta E, Vinberg M, Young AH, Mansur RB. Bipolar disorders. Lancet (London, England). 396: 1841-1856. PMID 33278937 DOI: 10.1016/S0140-6736(20)31544-0 |
0.01 |
|
2020 |
Lipsitz O, McIntyre RS, Rodrigues NB, Lee Y, Gill H, Subramaniapillai M, Kratiuk K, Nasri F, Mansur RB, Rosenblat JD. Does Body Mass Index Predict Response to Intravenous Ketamine Treatment in Adults with Major Depressive and Bipolar Disorder? Results from the Canadian Rapid Treatment Center of Excellence. Cns Spectrums. 1-28. PMID 33267928 DOI: 10.1017/S1092852920002102 |
0.01 |
|
2020 |
McIntyre RS, Chen VC, Lee Y, Lui LMW, Majeed A, Subramaniapillai M, Mansur RB, Rosenblat JD, Yang YH, Chen YL. The influence of prescriber and patient gender on the prescription of benzodiazepines: evidence for stereotypes and biases? Social Psychiatry and Psychiatric Epidemiology. PMID 33258001 DOI: 10.1007/s00127-020-01989-4 |
0.01 |
|
2020 |
Gill H, Gill B, Rodrigues NB, Lipsitz O, Rosenblat JD, El-Halabi S, Nasri F, Mansur RB, Lee Y, McIntyre RS. The Effects of Ketamine on Cognition in Treatment-Resistant Depression: A Systematic Review and Priority Avenues for Future Research. Neuroscience and Biobehavioral Reviews. PMID 33242561 DOI: 10.1016/j.neubiorev.2020.11.020 |
0.01 |
|
2020 |
Lee Y, Brietzke E, Cao B, Chen Y, Linnaranta O, Mansur RB, Cortes P, Kösters M, Majeed A, Tamura JK, Lui LMW, Vinberg M, Keinänen J, Kisely S, Naveed S, ... ... Rosenblat JD, et al. Development and implementation of guidelines for the management of depression: a systematic review. Bulletin of the World Health Organization. 98: 683-697H. PMID 33177758 DOI: 10.2471/BLT.20.251405 |
0.01 |
|
2020 |
Rosenblat JD, Li M. Is ketamine a litmus test for capacity in assisted dying with depression? Psycho-Oncology. PMID 33140440 DOI: 10.1002/pon.5586 |
0.01 |
|
2020 |
Park C, Majeed A, Gill H, Tamura J, Ho RC, Mansur RB, Nasri F, Lee Y, Rosenblat JD, Wong E, McIntyre RS. The Effect of Loneliness on Distinct Health Outcomes: A Comprehensive Review and Meta-Analysis. Psychiatry Research. 294: 113514. PMID 33130511 DOI: 10.1016/j.psychres.2020.113514 |
0.01 |
|
2020 |
McIntyre RS, Rodrigues NB, Lipsitz O, Nasri F, Gill H, Lui LM, Subramaniapillai M, Kratiuk K, Teopiz K, Ho R, Lee Y, Mansur RB, Rosenblat JD. The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence. Journal of Psychopharmacology (Oxford, England). 269881120954048. PMID 33040665 DOI: 10.1177/0269881120954048 |
0.01 |
|
2020 |
Lipsitz O, McIntyre RS, Rodrigues NB, Kaster TS, Cha DS, Brietzke E, Gill H, Nasri F, Lin K, Subramaniapillai M, Kratiuk K, Teopiz K, Lui LMW, Lee Y, Ho R, ... ... Rosenblat JD, et al. Early symptomatic improvements as a predictor of response to repeated-dose intravenous ketamine: Results from the Canadian rapid treatment center of excellence. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110126. PMID 33031861 DOI: 10.1016/j.pnpbp.2020.110126 |
0.01 |
|
2020 |
Gill H, Gill B, El-Halabi S, Chen-Li D, Lipsitz O, Rosenblat JD, Van Rheenen TE, Rodrigues NB, Mansur RB, Majeed A, Lui LMW, Nasri F, Lee Y, Mcintyre RS. Antidepressant Medications and Weight Change: A Narrative Review. Obesity (Silver Spring, Md.). PMID 33022115 DOI: 10.1002/oby.22969 |
0.01 |
|
2020 |
Gill H, Gill B, Chen-Li D, El-Halabi S, Rodrigues NB, Cha DS, Lipsitz O, Lee Y, Rosenblat JD, Majeed A, Mansur RB, Nasri F, Ho R, McIntyre RS. The Emerging Role of Psilocybin and MDMA in the Treatment of Mental Illness. Expert Review of Neurotherapeutics. PMID 32954860 DOI: 10.1080/14737175.2020.1826931 |
0.01 |
|
2020 |
Lipsitz O, McIntyre RS, Rodrigues NB, Lee Y, Cha DS, Gill H, Subramaniapillai M, Kratiuk K, Lin K, Ho R, Mansur RB, Rosenblat JD. Intravenous ketamine for postmenopausal women with treatment-resistant depression: Results from the Canadian Rapid Treatment Center of Excellence. Journal of Psychiatric Research. PMID 32948309 DOI: 10.1016/J.Jpsychires.2020.08.002 |
0.01 |
|
2020 |
McIntyre RS, Carvalho IP, Lui LMW, Majeed A, Masand PS, Gill H, Rodrigues NB, Lipsitz O, Coles AC, Lee Y, Tamura JK, Iacobucci M, Phan L, Nasri F, Singhal N, ... ... Rosenblat JD, et al. The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis. Journal of Affective Disorders. 276: 576-584. PMID 32871689 DOI: 10.1016/J.Jad.2020.06.050 |
0.01 |
|
2020 |
Rodrigues NB, McIntyre RS, Lipsitz O, Cha DS, Lee Y, Gill H, Majeed A, Phan L, Nasri F, Ho R, Lin K, Subramaniapillai M, Kratiuk K, Mansur RB, Rosenblat JD. Changes in symptoms of anhedonia in adults with major depressive or bipolar disorder receiving IV ketamine: Results from the Canadian Rapid Treatment Center of Excellence. Journal of Affective Disorders. 276: 570-575. PMID 32871688 DOI: 10.1016/J.Jad.2020.07.083 |
0.01 |
|
2020 |
Gill H, Perez CD, Gill B, El-Halabi S, Lee Y, Lipsitz O, Park C, Mansur RB, Rodrigues NB, McIntyre RS, Rosenblat JD. The prevalence of suicidal behaviour in fibromyalgia patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110078. PMID 32853715 DOI: 10.1016/J.Pnpbp.2020.110078 |
0.01 |
|
2020 |
Xu L, Zhang S, Chen W, Yan L, Chen Y, Wen H, Liu D, Rosenblat JD, Wang J, Cao B. Trace elements differences in the depression sensitive and resilient rat models. Biochemical and Biophysical Research Communications. 529: 204-209. PMID 32703412 DOI: 10.1016/j.bbrc.2020.05.228 |
0.01 |
|
2020 |
McIntyre RS, Subramaniapillai M, Park C, Zuckerman H, Cao B, Lee Y, Iacobucci M, Nasri F, Fus D, Bowie CR, Tran T, Rosenblat JD, Mansur RB. The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change. Frontiers in Psychiatry. 11: 546. PMID 32670103 DOI: 10.3389/Fpsyt.2020.00546 |
0.01 |
|
2020 |
McIntyre RS, Rodrigues NB, Lee Y, Lipsitz O, Subramaniapillai M, Gill H, Nasri F, Majeed A, Lui LMW, Senyk O, Phan L, Carvalho IP, Siegel A, Mansur RB, Brietzke E, ... ... Rosenblat JD, et al. The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence. Journal of Affective Disorders. 274: 903-910. PMID 32664031 DOI: 10.1016/J.Jad.2020.05.088 |
0.01 |
|
2020 |
Yim SJ, Lui LMW, Lee Y, Rosenblat JD, Ragguett RM, Park C, Subramaniapillai M, Cao B, Zhou A, Rong C, Lin K, Ho RC, Coles AS, Majeed A, Wong ER, et al. The utility of smartphone-based, ecological momentary assessment for depressive symptoms. Journal of Affective Disorders. 274: 602-609. PMID 32663993 DOI: 10.1016/J.Jad.2020.05.116 |
0.01 |
|
2020 |
Lee Y, Ragguett RM, Mansur RB, Boutilier JJ, Rosenblat JD, Trevizol A, Brietzke E, Lin K, Pan Z, Subramaniapillai M, Chan TCY, Fus D, Park C, Musial N, Zuckerman H, et al. Corrigendum to "Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review." J Affect Disord. 241 (2018) 519-532. Journal of Affective Disorders. 274: 1211-1215. PMID 32663953 DOI: 10.1016/J.Jad.2020.02.037 |
0.01 |
|
2020 |
Siegel AN, Rodrigues N, Nasri F, Wilkialis L, Lipsitz O, Lee Y, Gill H, Subramaniapillai M, Phan L, Majeed A, Lui LMW, Rashidian H, Ho R, Toma S, Goldstein BI, ... ... Rosenblat JD, et al. Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110032. PMID 32634540 DOI: 10.1016/J.Pnpbp.2020.110032 |
0.01 |
|
2020 |
Lee Y, Yang BX, Liu Q, Luo D, Kang L, Yang F, Ma S, Lu W, Chen-Li D, Rosenblat JD, Mansur RB, Nasri F, Subramaniapillai M, Liu Z, McIntyre RS, et al. The Synergistic Effect of Social Media Use and Psychological Distress on Depression in China During the COVID-19 Epidemic. Psychiatry and Clinical Neurosciences. PMID 32613732 DOI: 10.1111/Pcn.13101 |
0.01 |
|
2020 |
Lin K, Yang BX, Luo D, Liu Q, Ma S, Huang R, Lu W, Majeed A, Lee Y, Lui LMW, Mansur RB, Nasri F, Subramaniapillai M, Rosenblat JD, Liu Z, et al. The Mental Health Effects of COVID-19 on Health Care Providers in China. The American Journal of Psychiatry. 177: 635-636. PMID 32605443 DOI: 10.1176/Appi.Ajp.2020.20040374 |
0.01 |
|
2020 |
Mansur RB, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, Iacobucci M, Rodrigues N, Nasri F, Rashidian H, Rosenblat JD, Brietzke E, Cosgrove VE, Kramer NE, Suppes T, et al. Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression. Psychoneuroendocrinology. 120: 104779. PMID 32603956 DOI: 10.1016/J.Psyneuen.2020.104779 |
0.01 |
|
2020 |
Rodrigues NB, McIntyre RS, Lipsitz O, Lee Y, Cha DS, Nasri F, Gill H, Lui LMW, Subramaniapillai M, Kratiuk K, Lin K, Ho R, Mansur RB, Rosenblat JD. Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence. Expert Opinion On Drug Safety. 1-10. PMID 32539491 DOI: 10.1080/14740338.2020.1776699 |
0.01 |
|
2020 |
McIntyre RS, Lipsitz O, Rodrigues NB, Lee Y, Cha DS, Vinberg M, Lin K, Malhi GS, Subramaniapillai M, Kratiuk K, Fagiolini A, Gill H, Nasri F, Mansur RB, Suppes T, ... ... Rosenblat JD, et al. The Effectiveness of Ketamine on Anxiety, Irritability, and Agitation: Implications for Treating Mixed Features in Adults with Major Depressive or Bipolar Disorder. Bipolar Disorders. PMID 32406161 DOI: 10.1111/Bdi.12941 |
0.01 |
|
2020 |
Lee Y, Mansur RB, Brietzke E, Carmona NE, Subramaniapillai M, Pan Z, Shekotikhina M, Rosenblat JD, Suppes T, Cosgrove VE, Kramer NE, McIntyre RS. Efficacy of Adjunctive Infliximab vs. Placebo in the Treatment of Anhedonia in Bipolar I/II Depression. Brain, Behavior, and Immunity. PMID 32380271 DOI: 10.1016/J.Bbi.2020.04.063 |
0.01 |
|
2020 |
Gill H, El-Halabi S, Majeed A, Gill B, Lui LMW, Mansur RB, Lipsitz O, Rodrigues NB, Phan L, Chen-Li D, McIntyre RS, Rosenblat JD. The Association Between Adverse Childhood Experiences and Inflammation in Patients with Major Depressive Disorder: A Systematic Review. Journal of Affective Disorders. 272: 1-7. PMID 32379599 DOI: 10.1016/J.Jad.2020.03.145 |
0.01 |
|
2020 |
Rosenblat JD, Mansur RB, Brietzke E, Kennedy SH, Carvalho AF, Lee Y, Subramaniapillai M, Muzina DJ, Dale R, Tamura JK, Lui LMW, Park C, Phan L, Tuineag RM, McIntyre RS. Association of history of adverse childhood experiences with irritable bowel syndrome (IBS) in individuals with mood disorders. Psychiatry Research. 288: 112967. PMID 32339805 DOI: 10.1016/J.Psychres.2020.112967 |
0.01 |
|
2020 |
Peyrovian B, McIntyre RS, Phan L, Lui LMW, Gill H, Majeed A, Chen-Li D, Nasri F, Rosenblat JD. Registered clinical trials investigating ketamine for psychiatric disorders. Journal of Psychiatric Research. 127: 1-12. PMID 32315806 DOI: 10.1016/J.Jpsychires.2020.03.020 |
0.01 |
|
2020 |
Mansur RB, Delgado-Peraza F, Subramaniapillai M, Lee Y, Iacobucci M, Rodrigues N, Rosenblat JD, Brietzke E, Cosgrove VE, Kramer NE, Suppes T, Raison CL, Chawla S, Nogueras-Ortiz C, McIntyre RS, et al. Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression. Cells. 9. PMID 32268604 DOI: 10.3390/Cells9040895 |
0.01 |
|
2020 |
Rosenblat JD, Carvalho AF, Li M, Lee Y, Subramanieapillai M, McIntyre RS. Correction. The Journal of Clinical Psychiatry. 81. PMID 32220148 DOI: 10.4088/JCP.20lcx13315 |
0.01 |
|
2020 |
Kloiber S, Rosenblat JD, Husain MI, Ortiz A, Berk M, Quevedo J, Vieta E, Maes M, Birmaher B, Soares JC, Carvalho AF. Neurodevelopmental pathways in bipolar disorder. Neuroscience and Biobehavioral Reviews. PMID 32035092 DOI: 10.1016/J.Neubiorev.2020.02.005 |
0.01 |
|
2020 |
Rosenblat JD, McIntyre RS. Drs Rosenblat and McIntyre Reply. The Journal of Clinical Psychiatry. 81. PMID 31995675 DOI: 10.4088/Jcp.19Lr13146A |
0.01 |
|
2020 |
Park C, Zuckerman H, Subramaniapillai M, Mansur RB, Rosenblat JD, Cao B, Iacobucci M, Lee Y, Levitan R, Blumberger DM, McIntyre RS. Using early changes in cold cognition to predict response to vortioxetine in major depressive fisorder. Psychiatry Research. 284: 112767. PMID 31978627 DOI: 10.1016/J.Psychres.2020.112767 |
0.01 |
|
2019 |
Rosenblat JD. Trial of SAGE-217 in Patients with Major Depressive Disorder. The New England Journal of Medicine. 381: 2178-2179. PMID 31774968 DOI: 10.1056/NEJMc1913170#sa1 |
0.01 |
|
2019 |
Rosenblat JD, Kurdyak P, Cosci F, Berk M, Maes M, Brunoni AR, Li M, Rodin G, McIntyre RS, Carvalho AF. Depression in the medically ill. The Australian and New Zealand Journal of Psychiatry. 4867419888576. PMID 31749372 DOI: 10.1177/0004867419888576 |
0.01 |
|
2019 |
Park C, Zhu J, Man RHC, Rosenblat JD, Iacobucci M, Gill H, Mansur RB, McIntyre RS. Smartphone applications for the treatment of depressive symptoms: A meta-analysis and qualitative review. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 31: e12-e32. PMID 31675391 |
0.01 |
|
2019 |
Rashidian H, Rosenblat JD, McIntyre RS, Mansur RB. Leptin, obesity, and response to ketamine. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 98: 109773. PMID 31672525 DOI: 10.1016/J.Pnpbp.2019.109773 |
0.01 |
|
2019 |
Cao B, Park C, Rosenblat JD, Chen Y, Iacobucci M, Subramaniapillai M, Mansur RB, Zuckerman H, Lee Y, McIntyre RS. Changes in sleep predict changes in depressive symptoms in depressed subjects receiving vortioxetine: An open-label clinical trial. Journal of Psychopharmacology (Oxford, England). 269881119874485. PMID 31530216 DOI: 10.1177/0269881119874485 |
0.01 |
|
2019 |
Rosenblat JD. Potential differences in antidepressant effects of oral ketamine liquid suspension versus compounded capsules. The British Journal of Psychiatry : the Journal of Mental Science. 215: 434. PMID 31196248 DOI: 10.1192/bjp.2019.135 |
0.01 |
|
2019 |
McIntyre RS, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, Rosenblat JD, Brietzke E, Soczynska JK, Cosgrove VE, Miller S, Fischer EG, Kramer NE, Dunlap K, Suppes T, et al. Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression: A Randomized Clinical Trial. Jama Psychiatry. PMID 31066887 DOI: 10.1001/Jamapsychiatry.2019.0779 |
0.01 |
|
2019 |
Goldberg JF, Rosenblat JD, McIntyre RS, Preskorn SH, de Leon J. Clinical versus statistical significance of pharmacogenomic-guided antidepressant therapy: What's really being measured and marketed? Journal of Psychiatric Research. PMID 31064655 DOI: 10.1016/J.Jpsychires.2019.04.002 |
0.01 |
|
2019 |
Rosenblat JD, Goldberg JF, McIntyre RS. Consumer Warning for Genetic Tests Claiming to Predict Response to Medications: Implications for Psychiatry. The American Journal of Psychiatry. 176: 412-413. PMID 31039635 DOI: 10.1176/appi.ajp.2019.18121359 |
0.01 |
|
2019 |
Park C, Rosenblat J, Brietzke E, Pan Z, Lee Y, Cao B, Zuckerman H, Kalantarova A, McIntyre RS. Stress, Epigenetics and Depression: A Systematic Review. Neuroscience and Biobehavioral Reviews. PMID 31005627 DOI: 10.1016/J.Neubiorev.2019.04.010 |
0.01 |
|
2019 |
Rosenblat JD, Carvalho AF, Li M, Lee Y, Subramanieapillai M, McIntyre RS. Oral Ketamine for Depression: A Systematic Review. The Journal of Clinical Psychiatry. 80. PMID 30995364 DOI: 10.4088/Jcp.18R12475 |
0.01 |
|
2019 |
Park C, Rosenblat JD, Lee Y, Pan Z, Cao B, Iacobucci M, McIntyre RS. The Neural Systems of Emotion Regulation and Abnormalities in Major Depressive Disorder. Behavioural Brain Research. PMID 30951753 DOI: 10.1016/J.Bbr.2019.04.002 |
0.01 |
|
2019 |
Cao B, Wang DF, Yan LL, McIntyre RS, Rosenblat JD, Musial N, Liu YQ, Xie Q, Wang JY, Lu QB. Parental characteristics and the risk of schizophrenia in a Chinese population: a case-control study. Nordic Journal of Psychiatry. 1-6. PMID 30900499 DOI: 10.1080/08039488.2018.1529196 |
0.01 |
|
2019 |
Gill H, Kang S, Lee Y, Rosenblat JD, Brietzke E, Zuckerman H, McIntyre RS. The long-term effect of bariatric surgery on depression and anxiety. Journal of Affective Disorders. 246: 886-894. PMID 30795495 DOI: 10.1016/J.Jad.2018.12.113 |
0.01 |
|
2019 |
Rosenblat JD. Targeting the immune system in the treatment of bipolar disorder. Psychopharmacology. PMID 30756134 DOI: 10.1007/s00213-019-5175-x |
0.01 |
|
2019 |
Peyrovian B, Rosenblat JD, Pan Z, Iacobucci M, Brietzke E, McIntyre RS. The glycine site of NMDA receptors: A target for cognitive enhancement in psychiatric disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 30738126 DOI: 10.1016/J.Pnpbp.2019.02.001 |
0.01 |
|
2019 |
McIntyre RS, Anderson N, Baune BT, Brietzke E, Burdick K, Fossati P, Gorwood P, Harmer C, Harrison J, Harvey P, Mansur RB, Medalia A, Miskowiak K, Ramey T, Rong C, ... Rosenblat JD, et al. Expert Consensus on Screening and Assessment of Cognition in Psychiatry. Cns Spectrums. 1-9. PMID 30642417 DOI: 10.1017/S1092852918001189 |
0.01 |
|
2019 |
Cao B, Zhu J, Zuckerman H, Rosenblat JD, Brietzke E, Pan Z, Subramanieapillai M, Park C, Lee Y, McIntyre RS. Pharmacological interventions targeting anhedonia in patients with major depressive disorder: A systematic review. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 92: 109-117. PMID 30611836 DOI: 10.1016/J.Pnpbp.2019.01.002 |
0.01 |
|
2018 |
Shariq AS, Rosenblat JD, Alageel A, Mansur RB, Rong C, Ho RC, Ragguett RM, Pan Z, Brietzke E, McIntyre RS. Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 92: 1-7. PMID 30576764 DOI: 10.1016/J.Pnpbp.2018.12.008 |
0.01 |
|
2018 |
Rosenblat JD, Simon GE, Sachs GS, Deetz I, Doederlein A, DePeralta D, Dean MM, McIntyre RS. Factors That Impact Treatment Decisions: Results From an Online Survey of Individuals With Bipolar and Unipolar Depression. The Primary Care Companion For Cns Disorders. 20. PMID 30444959 DOI: 10.4088/Pcc.18M02340 |
0.01 |
|
2018 |
Rosenblat JD, Lee Y, Mansur RB, Brietzke E, McIntyre RS. Letter to the editor: Inadequate evidence to support improved patient outcomes with combinatorial pharmacogenomics. Journal of Psychiatric Research. 107: 136-137. PMID 30396048 DOI: 10.1016/J.Jpsychires.2018.10.017 |
0.01 |
|
2018 |
Parker G, Tavella G, Macqueen G, Berk M, Grunze H, Deckersbach T, Dunner DL, Sajatovic M, Amsterdam JD, Ketter TA, Yatham LN, Kessing LV, Bassett D, Zimmerman M, Fountoulakis KN, ... ... Rosenblat JD, et al. Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project. The Australian and New Zealand Journal of Psychiatry. 4867418808382. PMID 30378461 DOI: 10.1177/0004867418808382 |
0.01 |
|
2018 |
Cha DS, Carmona N, Cha RH, Zhou AJ, Subramaniapillai M, Mansur RB, Lee Y, Lee JH, Lee J, Almatham F, Alageel A, Rosenblat JD, Shekotikhina M, Rong C, Harrison J, et al. Perceived sleep quality predicts cognitive function in adults with major depressive disorder independent of depression severity. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 30: e1-e10. PMID 30372511 |
0.01 |
|
2018 |
Rosenblat JD, Simon GE, Sachs GS, Deetz I, Doederlein A, DePeralta D, Dean MM, McIntyre RS. Frequency of use and perceived helpfulness of wellness strategies for bipolar and unipolar depression. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 30: 296-304. PMID 30372507 |
0.01 |
|
2018 |
Rosenblat JD, Simon GE, Sachs GS, Deetz I, Doederlein A, DePeralta D, Dean MM, McIntyre RS. Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression. Journal of Affective Disorders. 243: 116-120. PMID 30241026 DOI: 10.1016/J.Jad.2018.09.027 |
0.01 |
|
2018 |
McIntyre RS, Lee Y, Carmona NE, Subramaniapillai M, Cha DS, Lee J, Lee JH, Alageel A, Rodrigues NB, Park C, Ragguett RM, Rosenblat JE, Almatham F, Pan Z, Rong C, et al. Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder. Harvard Review of Psychiatry. 26: 241-249. PMID 30188336 DOI: 10.1097/Hrp.0000000000000171 |
0.01 |
|
2018 |
Liu D, Cao B, Zhao Y, Huang H, McIntyre RS, Rosenblat JD, Zhou H. Soluble TREM2 changes during the clinical course of Alzheimer's disease: A meta-analysis. Neuroscience Letters. PMID 30171911 DOI: 10.1016/J.Neulet.2018.08.038 |
0.01 |
|
2018 |
Cao B, Jin M, Brietzke E, McIntyre RS, Wang D, Rosenblat JD, Ragguett RM, Zhang C, Sun X, Rong C, Wang J. Serum Metabolic Profiling using Small Molecular Water-Soluble Metabolites in Individuals with Schizophrenia: A Longitudinal Study using a Pre-Post Treatment Design. Psychiatry and Clinical Neurosciences. PMID 30156046 DOI: 10.1111/Pcn.12779 |
0.01 |
|
2018 |
Lee Y, Ragguett RM, Mansur RB, Boutilier JJ, Rosenblat JD, Trevizol A, Brietzke E, Lin K, Pan Z, Subramaniapillai M, Chan TCY, Fus D, Park C, Musial N, Zuckerman H, et al. Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review. Journal of Affective Disorders. 241: 519-532. PMID 30153635 DOI: 10.1016/J.Jad.2018.08.073 |
0.01 |
|
2018 |
Rosenblat JD, Lee Y, McIntyre RS. The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis. Journal of Affective Disorders. 241: 484-491. PMID 30149336 DOI: 10.1016/J.Jad.2018.08.056 |
0.01 |
|
2018 |
Brietzke E, Mansur RB, Subramaniapillai M, Martinez VB, Vinberg M, González-Pinto A, Rosenblat JD, Ho R, McIntyre RS. KETOGENIC DIET AS A METABOLIC THERAPY FOR MOOD DISORDERS: EVIDENCE AND DEVELOPMENTS. Neuroscience and Biobehavioral Reviews. PMID 30075165 DOI: 10.1016/J.Neubiorev.2018.07.020 |
0.01 |
|
2018 |
Park C, Pan Z, Brietzke E, Subramaniapillai M, Rosenblat JD, Zuckerman H, Lee Y, Fus D, McIntyre RS. Predicting Antidepressant Response Using Early Changes in Cognition: A Systematic Review. Behavioural Brain Research. PMID 30031025 DOI: 10.1016/J.Bbr.2018.07.011 |
0.01 |
|
2018 |
Park C, Brietzke E, Rosenblat JD, Musial N, Zuckerman H, Ragguett RM, Pan Z, Rong C, Fus D, McIntyre RS. Probiotics for the Treatment of Depressive Symptoms: An Anti-Inflammatory Mechanism? Brain, Behavior, and Immunity. PMID 30009996 DOI: 10.1016/J.Bbi.2018.07.006 |
0.01 |
|
2018 |
Shariq AS, Brietzke E, Rosenblat JD, Pan Z, Rong C, Ragguett RM, Park C, McIntyre RS. Therapeutic potential of JAK/STAT pathway modulation in mood disorders. Reviews in the Neurosciences. PMID 29902157 DOI: 10.1515/Revneuro-2018-0027 |
0.01 |
|
2018 |
Cha DS, Carmona NE, Rodrigues NB, Mansur RB, Lee Y, Subramaniapillai M, Phan L, Cha RH, Pan Z, Lee JH, Lee J, Almatham F, Alageel A, Rosenblat JD, Shekotikhina M, et al. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder. Journal of Affective Disorders. 238: 228-232. PMID 29886204 DOI: 10.1016/J.Jad.2018.05.006 |
0.01 |
|
2018 |
Alageel A, Tomasi J, Tersigni C, Brietzke E, Zuckerman H, Subramaniapillai M, Lee Y, Iacobucci M, Rosenblat JD, Mansur RB, McIntyre RS. Evidence supporting a mechanistic role of sirtuins in mood and metabolic disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 86: 95-101. PMID 29802856 DOI: 10.1016/J.Pnpbp.2018.05.017 |
0.01 |
|
2018 |
Cao B, Wang D, Brietzke E, McIntyre RS, Pan Z, Cha D, Rosenblat JD, Zuckerman H, Liu Y, Xie Q, Wang J. Characterizing amino-acid biosignatures amongst individuals with schizophrenia: a case-control study. Amino Acids. PMID 29796929 DOI: 10.1007/S00726-018-2579-6 |
0.01 |
|
2018 |
Cao B, Rosenblat JD, Brietzke E, Park C, Lee Y, Musial N, Pan Z, Mansur RB, McIntyre RS. Comparative Efficacy and Acceptability of Anti-Diabetic Agents for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Network Meta-analysis. Diabetes, Obesity & Metabolism. PMID 29790638 DOI: 10.1111/Dom.13373 |
0.01 |
|
2018 |
Rosenblat JD, Smith S, McIntyre RS. Are Antidepressants Harmful in the "General Population"? Psychotherapy and Psychosomatics. 1. PMID 29723856 DOI: 10.1159/000487894 |
0.01 |
|
2018 |
Rong C, Park C, Rosenblat JD, Subramaniapillai M, Zuckerman H, Fus D, Lee YL, Pan Z, Brietzke E, Mansur RB, Cha DS, Lui LMW, McIntyre RS. Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder. International Journal of Environmental Research and Public Health. 15. PMID 29673146 DOI: 10.3390/Ijerph15040771 |
0.01 |
|
2018 |
Ragguett RM, Rong C, Rosenblat JD, Ho RC, McIntyre RS. Pharmacodynamic and pharmacokinetic evaluation of buprenorphine + samidorphan for the treatment of major depressive disorder. Expert Opinion On Drug Metabolism & Toxicology. 1-8. PMID 29621905 DOI: 10.1080/17425255.2018.1459564 |
0.01 |
|
2018 |
Mansur RB, Lee Y, Zhou AJ, Carmona NE, Cha DS, Rosenblat JD, Bruins R, Kakar R, Rasgon NL, Lovshin JA, Wroolie TE, Sim K, Brietzke E, Gerstein HC, Rong C, et al. Determinants of cognitive function in individuals with type 2 diabetes mellitus: A meta-analysis. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 30: 38-50. PMID 29373617 |
0.01 |
|
2018 |
Shariq AS, Brietzke E, Rosenblat JD, Barendra V, Pan Z, McIntyre RS. Targeting cytokines in reduction of depressive symptoms: A comprehensive review. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 29309829 DOI: 10.1016/J.Pnpbp.2018.01.003 |
0.01 |
|
2017 |
Lee Y, Rosenblat JD, Lee J, Carmona NE, Subramaniapillai M, Shekotikhina M, Mansur RB, Brietzke E, Lee JH, Ho RC, Yim SJ, McIntyre RS. Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review. Journal of Affective Disorders. 227: 406-415. PMID 29154157 DOI: 10.1016/J.Jad.2017.11.003 |
0.01 |
|
2017 |
Rosenblat JD, McIntyre RS. Efficacy and tolerability of minocycline for depression: A systematic review and meta-analysis of clinical trials. Journal of Affective Disorders. 227: 219-225. PMID 29102836 DOI: 10.1016/J.Jad.2017.10.042 |
0.01 |
|
2017 |
Rosenblat JD, McIntyre RS. Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications. Brain Sciences. 7. PMID 29084144 DOI: 10.3390/Brainsci7110144 |
0.01 |
|
2017 |
Rong C, Carmona NE, Lee YL, Ragguett RM, Pan Z, Rosenblat JD, Subramaniapillai M, Shekotikhina M, Almatham F, Alageel A, Mansur R, Ho RC, McIntyre RS. Drug-Drug Interactions as a Result of Co-Administering Δ(9)-THC and CBD with Other Psychotropic Agents. Expert Opinion On Drug Safety. PMID 29082802 DOI: 10.1080/14740338.2017.1397128 |
0.01 |
|
2017 |
Cha DS, Carmona NE, Mansur RB, Lee Y, Park HJ, Rodrigues NB, Subramaniapillai M, Rosenblat JD, Pan Z, Lee JH, Lee J, Almatham F, Alageel A, Shekotikhina M, Zhou AJ, et al. Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it). Scandinavian Journal of Pain. 15: 62-67. PMID 28850348 DOI: 10.1016/J.Sjpain.2016.12.004 |
0.01 |
|
2017 |
Perera JK, Rosenblat JD, Flint AJ. Dementia with Lewy bodies presenting as psychotic depression. The Australian and New Zealand Journal of Psychiatry. 4867417720036. PMID 28709381 DOI: 10.1177/0004867417720036 |
0.01 |
|
2017 |
Cha DS, Carmona NE, Subramaniapillai M, Mansur RB, Lee Y, Hon Lee J, Lee J, Rosenblat JD, Shekotikhina M, Park C, Rong C, Greer TL, Lam R, Baune BT, Harrison J, et al. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder. Journal of Affective Disorders. 222: 14-20. PMID 28667888 DOI: 10.1016/J.Jad.2017.06.036 |
0.01 |
|
2017 |
McIntyre RS, Lee Y, Zhou AJ, Rosenblat JD, Peters EM, Lam RW, Kennedy SH, Rong C, Jerrell JM. The Efficacy of Psychostimulants in Major Depressive Episodes: A Systematic Review and Meta-Analysis. Journal of Clinical Psychopharmacology. PMID 28590365 DOI: 10.1097/Jcp.0000000000000723 |
0.01 |
|
2017 |
Rong C, Lee Y, Carmona NE, Cha DS, Ragguett RM, Rosenblat JD, Mansur RB, Ho RC, McIntyre RS. Cannabidiol in Medical Marijuana: Research Vistas and Potential Opportunities. Pharmacological Research. PMID 28501518 DOI: 10.1016/J.Phrs.2017.05.005 |
0.01 |
|
2017 |
Brown GM, McIntyre RS, Rosenblat J, Hardeland R. Depressive disorders: Processes leading to neurogeneration and potential novel treatments. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28433459 DOI: 10.1016/J.Pnpbp.2017.04.023 |
0.01 |
|
2017 |
Stahl SM, Morrissette DA, Faedda G, Fava M, Goldberg JF, Keck PE, Lee Y, Malhi G, Marangoni C, McElroy SL, Ostacher M, Rosenblat JD, Solé E, Suppes T, Takeshima M, et al. Guidelines for the recognition and management of mixed depression. Cns Spectrums. 1-17. PMID 28421980 DOI: 10.1017/S1092852917000165 |
0.01 |
|
2017 |
SayuriYamagata A, Brietzke E, Rosenblat JD, Kakar R, McIntyre RS. Medical comorbidity in bipolar disorder: The link with metabolic-inflammatory systems. Journal of Affective Disorders. 211: 99-106. PMID 28107669 DOI: 10.1016/J.Jad.2016.12.059 |
0.01 |
|
2017 |
Pan Z, Rosenblat JD, Swardfager W, McIntyre RS. Role of proinflammatory cytokines in dopaminergic system disturbances, implications for anhedonic features of MDD. Current Pharmaceutical Design. PMID 28078987 DOI: 10.2174/1381612823666170111144340 |
0.01 |
|
2017 |
Rosenblat JD, Lee Y, McIntyre RS. Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder? A Systematic Review of Clinical Trials and Cost-Effectiveness Studies. The Journal of Clinical Psychiatry. PMID 28068459 DOI: 10.4088/Jcp.15R10583 |
0.01 |
|
2017 |
Rosenblat JD, McIntyre RS. Treatment recommendations for DSM-5-defined mixed features. Cns Spectrums. 22: 147-154. PMID 27629159 DOI: 10.1017/S1092852916000432 |
0.01 |
|
2017 |
Rosenblat JD, McIntyre RS. Treatment of mixed features in bipolar disorder. Cns Spectrums. 22: 141-146. PMID 27618746 DOI: 10.1017/S1092852916000547 |
0.01 |
|
2016 |
Gregory JM, Rosenblat JD, McIntyre RS. Deconstructing Diabetes and Depression: Clinical Context, Treatment Strategies, and New Directions. Focus (American Psychiatric Publishing). 14: 184-193. PMID 31975802 DOI: 10.1176/appi.focus.20150040 |
0.01 |
|
2016 |
Ragguett RM, Cha DS, Kakar R, Rosenblat JD, Lee Y, McIntyre RS. Assessing and measuring cognitive function in major depressive disorder. Evidence-Based Mental Health. 19: 106-109. PMID 27935809 DOI: 10.1136/Eb-2016-102456 |
0.01 |
|
2016 |
Rosenblat JD, Gregory JM, McIntyre RS. Pharmacologic implications of inflammatory comorbidity in bipolar disorder. Current Opinion in Pharmacology. 29: 63-69. PMID 27400335 DOI: 10.1016/J.Coph.2016.06.007 |
0.01 |
|
2016 |
Rosenblat JD, Kakar R, Berk M, Kessing LV, Vinberg M, Baune BT, Mansur RB, Brietzke E, Goldstein BI, McIntyre RS. Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. Bipolar Disorders. PMID 26990051 DOI: 10.1111/Bdi.12373 |
0.01 |
|
2016 |
Swardfager W, Rosenblat JD, Benlamri M, McIntyre RS. Mapping inflammation onto mood: Inflammatory mediators of anhedonia. Neuroscience and Biobehavioral Reviews. 64: 148-66. PMID 26915929 DOI: 10.1016/J.Neubiorev.2016.02.017 |
0.01 |
|
2016 |
Rosenblat JD, McIntyre RS. Bipolar Disorder and Inflammation. The Psychiatric Clinics of North America. 39: 125-37. PMID 26876323 DOI: 10.1016/J.Psc.2015.09.006 |
0.01 |
|
2016 |
Woo YS, Rosenblat JD, Kakar R, Bahk WM, McIntyre RS. Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients. Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology. 14: 1-16. PMID 26792035 DOI: 10.9758/Cpn.2016.14.1.1 |
0.01 |
|
2016 |
Cooper MD, Rosenblat JD, Cha DS, Lee Y, Kakar R, McIntyre RS. Strategies to Mitigate Dissociative and Psychotomimetic Effects of Ketamine in the Treatment of Major Depressive Episodes: A Narrative Review. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-42. PMID 26752601 DOI: 10.3109/15622975.2016.1139747 |
0.01 |
|
2015 |
Lee Y, Syeda K, Maruschak NA, Cha DS, Mansur RB, Wium-Andersen IK, Woldeyohannes HO, Rosenblat JD, McIntyre RS. A New Perspective on the Anti-Suicide Effects With Ketamine Treatment: A Procognitive Effect. Journal of Clinical Psychopharmacology. PMID 26658082 DOI: 10.1097/Jcp.0000000000000441 |
0.01 |
|
2015 |
Rosenblat JD, McIntyre RS, Alves GS, Fountoulakis KN, Carvalho AF. Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review. Current Neuropharmacology. 13: 636-55. PMID 26467412 DOI: 10.2174/1570159X13666150630175044 |
0.01 |
|
2015 |
Cao WJ, Rosenblat JD, Roth NC, Kuliszewski MA, Matkar PN, Rudenko D, Liao C, Lee PJ, Leong-Poi H. Therapeutic Angiogenesis by Ultrasound-Mediated MicroRNA-126-3p Delivery. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 26381870 DOI: 10.1161/ATVBAHA.115.306506 |
0.01 |
|
2015 |
Rosenblat JD, Brietzke E, Mansur RB, Maruschak NA, Lee Y, McIntyre RS. Inflammation as a neurobiological substrate of cognitive impairment in bipolar disorder: Evidence, pathophysiology and treatment implications. Journal of Affective Disorders. 188: 149-59. PMID 26363613 DOI: 10.1016/J.Jad.2015.08.058 |
0.01 |
|
2015 |
Rosenblat JD, Kakar R, McIntyre RS. The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. The International Journal of Neuropsychopharmacology. 19. PMID 26209859 DOI: 10.1093/Ijnp/Pyv082 |
0.01 |
|
2014 |
Cha DS, Carvalho AF, Rosenblat JD, Ali MM, McIntyre RS. Major depressive disorder and type II diabetes mellitus: mechanisms underlying risk for Alzheimer's disease. Cns & Neurological Disorders Drug Targets. 13: 1740-9. PMID 25470393 DOI: 10.2174/1871527313666141130204535 |
0.01 |
|
2014 |
Rosenblat JD, Cha DS, Mansur RB, McIntyre RS. Inflamed moods: a review of the interactions between inflammation and mood disorders. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 53: 23-34. PMID 24468642 DOI: 10.1016/J.Pnpbp.2014.01.013 |
0.01 |
|
2013 |
Rosenblat JD, Devarajan S. Resolution of electroconvulsive therapy refractory major depressive disorder with unintentional hypoglycemic seizure: a case report. The Journal of Ect. 29: e47-8. PMID 23670025 DOI: 10.1097/YCT.0b013e318290fc20 |
0.01 |
|
2011 |
Dunne M, Zheng J, Rosenblat J, Jaffray DA, Allen C. APN/CD13-targeting as a strategy to alter the tumor accumulation of liposomes. Journal of Controlled Release : Official Journal of the Controlled Release Society. 154: 298-305. PMID 21640146 DOI: 10.1016/J.Jconrel.2011.05.022 |
0.01 |
|
Hide low-probability matches. |